AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (November 24, 2004). doi:10.1152/ajpheart.00996.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/4/H1786    most recent
00996.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swafford, A. N.
Right arrow Articles by Dick, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swafford, A. N.
Right arrow Articles by Dick, G. M.
Submitted on September 28, 2004
Accepted on November 18, 2004

C-Reactive Protein Does Not Relax Vascular Smooth Muscle: Effects Mediated by Sodium Azide in Commercially Available Preparations

Albert N. Swafford1, Ian N. Bratz1, Jarrod D. Knudson1, Paul A. Rogers1, Jennifer M. Timmerman1, Johnathan D. Tune1, and Gregory M. Dick1*

1 Department of Physiology, LSU Health Sciences Center, New Orleans, LA, USA

* To whom correspondence should be addressed. E-mail: gdick{at}lsuhsc.edu.

C-reactive protein (CRP), an acute phase protein and newly recognized indicator of cardiovascular risk, may have direct actions on the vascular wall. Previous studies suggest CRP is a vasodilator that activates smooth muscle K+ channels. We examined the reported vasoactive properties of CRP and further explored mechanisms of action. CRP decreased blood pressure in rats and increased coronary flow in open-chest dogs at a constant coronary perfusion pressure. CRP relaxed rat aortic rings and mesenteric small arteries contracted with phenylephrine. Relaxation was not affected by endothelial denudation or inhibition of nitric oxide synthase but was blocked by inhibiting soluble guanylate cyclase or K+ channels. CRP solutions remained effective, i.e., elicited vasodilation, even after boiling or enzymatic digestion, suggesting the presence of a non-protein contaminant. Sodium azide (NaN3; 0.1%) is the preservative used for commercially available CRP and a potential source of nitric oxide (NO). NaN3 elicited the same cardiovascular effects as CRP preparations at equal concentrations and its actions were blocked by inhibiting guanylate cyclase and K+ channels. Azide-free CRP, prepared by gel filtration centrifugation and confirmed by electrophoresis, had no effect on vascular tone. Inhibition of vascular smooth muscle catalase with 3-amino-1,2,4-triazole completely prevented the effects of NaN3 and azide-containing CRP solutions. We demonstrate that the acute vasoactive properties of commercially available CRP preparations are attributable to NaN3 (and subsequent production of NO by catalase); therefore, the study suggests a reappraisal of the acute role of CRP in regulating vascular tone.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. M. Dick, I. N. Bratz, L. Borbouse, G. A. Payne, U. D. Dincer, J. D. Knudson, P. A. Rogers, and J. D. Tune
Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary circulation
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2371 - H2381.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Kuji, T. Masaki, L. Li, and A. K. Cheung
Expression of C-reactive protein in myointimal hyperplasia in a porcine arteriovenous graft model
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2469 - 2475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Grad, M. Golomb, I. Mor-Yosef, N. Koroukhov, C. Lotan, E. R. Edelman, and H. D. Danenberg
Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H489 - H495.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Schwartz, S. Osborne-Lawrence, L. Hahner, L. L. Gibson, A. K. Gormley, W. Vongpatanasin, W. Zhu, R. A. Word, D. Seetharam, S. Black, et al.
C-Reactive Protein Downregulates Endothelial NO Synthase and Attenuates Reendothelialization In Vivo in Mice
Circ. Res., May 25, 2007; 100(10): 1452 - 1459.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Zhong, S.-H. Li, S.-M. Liu, P. E. Szmitko, X.-Q. He, P. W.M. Fedak, and S. Verma
C-Reactive Protein Upregulates Receptor for Advanced Glycation End Products Expression in Human Endothelial Cells
Hypertension, September 1, 2006; 48(3): 504 - 511.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
J. P Casas, T. Shah, J. Cooper, E. Hawe, A. D McMahon, D. Gaffney, C. J Packard, D. S O'Reilly, I. Juhan-Vague, J. S Yudkin, et al.
Insight into the nature of the CRP-coronary event association using Mendelian randomization
Int. J. Epidemiol., August 1, 2006; 35(4): 922 - 931.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Paffen and M. P.M. deMaat
C-reactive protein in atherosclerosis: A causal factor?
Cardiovasc Res, July 1, 2006; 71(1): 30 - 39.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
G. Doronzo, I. Russo, M. Trovati, and G. Anfossi
Sodium azide in commercially available C-reactive protein preparations does not influence matrix metalloproteinase-2 synthesis and release in cultured human aortic vascular smooth muscle cells.
Clin. Chem., June 1, 2006; 52(6): 1200 - 1201.
[Full Text] [PDF]


Home page
Int ImmunolHome page
M. Oroszlan, E. Herczenik, S. Rugonfalvi-Kiss, A. Roos, A. J Nauta, M. R Daha, I. Gombos, I. Karadi, L. Romics, Z. Prohaszka, et al.
Proinflammatory changes in human umbilical cord vein endothelial cells can be induced neither by native nor by modified CRP
Int. Immunol., June 1, 2006; 18(6): 871 - 878.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev, April 1, 2006; 86(2): 515 - 581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Qamirani, H. M. Razavi, X. Wu, M. J. Davis, L. Kuo, and T. W. Hein
Sodium azide dilates coronary arterioles via activation of inward rectifier K+ channels and Na+-K+-ATPase
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1617 - H1623.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. B. Pepys, P. N. Hawkins, M. C. Kahan, G. A. Tennent, J. R. Gallimore, D. Graham, C. A. Sabin, A. Zychlinsky, and J. de Diego
Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein Itself
Circ. Res., November 25, 2005; 97(11): e97 - e103.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Liu, S. Wang, A. Deb, K. A. Nath, Z. S. Katusic, J. P. McConnell, and N. M. Caplice
Proapoptotic, Antimigratory, Antiproliferative, and Antiangiogenic Effects of Commercial C-Reactive Protein on Various Human Endothelial Cell Types In Vitro: Implications of Contaminating Presence of Sodium Azide in Commercial Preparation
Circ. Res., July 22, 2005; 97(2): 135 - 143.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. W. van den Berg and K. E. Taylor
Letter to the Editor: Letter in Response to Bisoendial et al: "Activation of Inflammation and Coagulation After Infusion of C-Reactive Protein in Humans"
Circ. Res., July 8, 2005; 97(1): e2 - e2.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.